Does hypertonic saline activate CD4+ and CD8+ T-lymphocytes in the small intestine to alleviate intestinal ischemia-reperfusion injury?
HS treatment may ameliorate the tissue damage induced by intestinal I/R. This protective effect is possibly due to its ability to activate the CD4(+) and CD8(+) T-lymphocytes cells in the intestinal tissues and inhibit the intestinal I/R-induced expression of pro-inflammatory cytokines.
Of the two MRA 'misses', neither would have resulted in different management. MRA is a safe and accurate modality for follow-up of coiled aneurysms and can replace DSA.